Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
1.200
+0.040 (3.45%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Aspire Biopharma Holdings Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 1.95 | 0 | 0.01 | 0 |
| Cash & Short-Term Investments | 1.95 | 0 | 0.01 | 0 |
| Cash Growth | 11678.43% | -67.49% | 29305.26% | - |
| Prepaid Expenses | 0.42 | 0.14 | 0.04 | 0.02 |
| Total Current Assets | 2.4 | 0.15 | 0.05 | 0.02 |
| Accounts Payable | 1.06 | 0.31 | 0.17 | 0.12 |
| Short-Term Debt | 8.62 | 1.27 | 0.36 | 0.03 |
| Other Current Liabilities | 3.55 | 0.11 | 0 | 0 |
| Total Current Liabilities | 13.86 | 1.69 | 0.53 | 0.15 |
| Other Long-Term Liabilities | 0.01 | - | - | 0 |
| Common Stock | 0 | 0.02 | 0.02 | 0.22 |
| Additional Paid-In Capital | 11.08 | 1.22 | 0.96 | 0.76 |
| Retained Earnings | -22.55 | -2.78 | -1.47 | -1.11 |
| Total Common Equity | -11.47 | -1.54 | -0.49 | -0.13 |
| Total Liabilities & Equity | 2.4 | 0.15 | 0.05 | 0.02 |
| Total Debt | 8.62 | 1.27 | 0.36 | 0.03 |
| Net Cash (Debt) | -6.68 | -1.26 | -0.35 | -0.03 |
| Net Cash Per Share | -5.39 | -0.11 | -0.00 | - |
| Filing Date Shares Outstanding | 2.69 | 440 | 443.32 | - |
| Total Common Shares Outstanding | 1.24 | 440 | 443 | - |
| Working Capital | -11.46 | -1.54 | -0.49 | -0.13 |
| Book Value Per Share | -9.26 | -0.00 | -0.00 | - |
| Tangible Book Value | -11.47 | -1.54 | -0.49 | -0.13 |
| Tangible Book Value Per Share | -9.26 | -0.00 | -0.00 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.